PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA,
pronounced /ˈfɑrmə/), founded in 1958, is a trade group
representing companies in the pharmaceutical industry in the United
States . PhRMA's stated mission is advocacy for public policies that
encourage the discovery of new medicines for patients by companies
engaged in pharmaceutical and biopharmaceutical research . Steve Ubl
became PhRMA's chairman in September 2015.
* 1 Leadership
* 2 Programs
* 3 See also
* 4 References
* 5 External links
George A. Scangos , CEO of
Biogen , is chairman of the PhRMA board.
Joaquin Duato , chairman of Johnson -webkit-column-width: 30em;
column-width: 30em; list-style-type: decimal;">
* ^ The Editorial Board (November 27, 2015). "Turn the Volume Down
on Drug Ads".
New York Times
New York Times . Retrieved November 27, 2015.
* ^ Stephen J. Ubl to Lead PhRMA as Next President and CEO. PhRMA
website. September 25, 2015
* ^ "
Biogen CEO George A. Scangos Becomes PhRMA Board Chairman".
PhRMA. March 10, 2016.
* ^ whorunsgov.com
* ^ N.C. Alzenman and Dan Eggen (July 14, 2010). "Pharmaceutical
group shifts tone with new pick for president". The Washington Post.
* ^ Judy Sarasohn (December 16, 2004). "
Special Interests: Tauzin
to Head Drug Trade Group". The Washington Post. p. A35.
* ^ Julian Pecquet (July 14, 2010). "PhRMA picks new president". 17
(81). The Hill. p. 22.
* ^ A B "Patient Resources". Pharmaceutical Research and
Manufacturers of America. Archived from the original on March 19,
2011. Retrieved April 6, 2011.
* ^ "Marathon gets the Shkreli treatment from industry after $89K
drug dust up". Ars Technica. Retrieved 2017-02-18.